Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 726-732

  Bakema, Jantine E ^a   Ganzevles, Sonja H ^a   Fluitsma, Donna M ^a   Schilham, Marco W ^b   Beelen, Robert H J ^a   Valerius, Thomas ^c   Lohse, Stefan ^c   Glennie, Martin J ^d   Medema, Jan Paul ^e   Van Egmond, Marjolein ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A ANTIBODY;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BREAST CARCINOMA; CARCINOMA CELL; CELL DEATH; CELL VACUOLE; CELL VIABILITY; COCULTURE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; EFFECTOR CELL; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; MEMBRANE VESICLE; NEUTROPHIL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; TUMOR CELL;

ANTIBODIES, BISPECIFIC; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; GENE TARGETING; HUMANS; IMMUNOGLOBULIN A; NEUTROPHILS; RECEPTORS, FC;

EID: 79960541647     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002581     Document Type: Article

References (48)

1. Weiner, L. M., M. V. Dhodapkar, and S. Ferrone. 2009. Monoclonal antibodies for cancer immunotherapy. Lancet 373: 1033-1040.
2. Glennie, M. J., and J. G. van de Winkel. 2003. Renaissance of cancer therapeutic antibodies. Drug Discov. Today 8: 503-510. (Pubitemid 36724584)
3. Iannello, A., and A. Ahmad. 2005. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies. Cancer Metastasis Rev. 24: 487-499. (Pubitemid 43096997)
4. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529.
5. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290.
6. Otten, M. A., G. J. van der Bij, S. J. Verbeek, F. Nimmerjahn, J. V. Ravetch, R. H. Beelen, J. G. van de Winkel, and M. van Egmond. 2008. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J. Immunol. 181: 6829-6836.
7. Valerius, T., D. Würflein, B. Stockmeyer, R. Repp, J. R. Kalden, and M. Gramatzki. 1997. Activated neutrophils as effector cells for bispecific antibodies. Cancer Immunol. Immunother. 45: 142-145.
8. Valerius, T., R. Repp, T. P. de Wit, S. Berthold, E. Platzer, J. R. Kalden, M. Gramatzki, and J. G. van de Winkel. 1993. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82: 931-939. (Pubitemid 23221678)
9. Lieschke, G. J., and A. W. Burgess. 1992. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N. Engl. J. Med. 327: 99-106.
10. Yang, D., Q. Chen, O. Chertov, and J. J. Oppenheim. 2000. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 68: 9-14.
11. Valerius, T., D. Elsässer, R. Repp, J. G. Van de Winkel, M. Gramatzki, and M. Glennie. 1997. HLA class II antibodies recruit G-CSF activated neutrophils for treatment of B cell malignancies. Leuk. Lymphoma 26: 261-269. (Pubitemid 27401909)
12. van Egmond, M. 2008. Neutrophils in antibody-based immunotherapy of cancer. Expert Opin. Biol. Ther. 8: 83-94.
13. Valerius, T., B. Stockmeyer, A. B. van Spriel, R. F. Graziano, I. E. van den Herik-Oudijk, R. Repp, Y. M. Deo, J. Lund, J. R. Kalden, M. Gramatzki, and J. G. van de Winkel. 1997. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy. Blood 90: 4485-4492. (Pubitemid 27508454)
14. Stockmeyer, B., M. Dechant, M. van Egmond, A. L. Tutt, K. Sundarapandiyan, R. F. Graziano, R. Repp, J. R. Kalden, M. Gramatzki, M. J. Glennie, et al. 2000. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J. Immunol. 165: 5954-5961.
15. Otten, M. A., E. Rudolph, M. Dechant, C. W. Tuk, R. M. Reijmers, R. H. Beelen, J. G. van de Winkel, and M. van Egmond. 2005. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J. Immunol. 174: 5472-5480. (Pubitemid 40593187)
16. Melino, G., R. A. Knight, and P. Nicotera. 2005. How many ways to die? How many different models of cell death? Cell Death Differ. 12(Suppl. 2): 1457-1462.
17. Edinger, A. L., and C. B. Thompson. 2004. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 16: 663-669.
18. Amaravadi, R. K., and C. B. Thompson. 2007. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13: 7271-7279.
19. Clarke, P. G. 1990. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. (Berl.) 181: 195-213.
20. Kroemer, G., and B. Levine. 2008. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9: 1004-1010.
21. Mizushima, N., T. Yoshimori, and B. Levine. 2010. Methods in mammalian autophagy research. Cell 140: 313-326.
22. Mizushima, N., B. Levine, A. M. Cuervo, and D. J. Klionsky. 2008. Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075.
23. Nelson, D. L., C. C. Kurman, and D. E. Serbousek. 2001. 51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC). Curr. Protoc. Immunol. Chapter 7:Unit 7.27.
24. Valentijn, A. J., N. Zouq, and A. P. Gilmore. 2004. Anoikis. Biochem. Soc. Trans. 32: 421-425.
25. Verhoeven, D. H., A. S. de Hooge, E. C. Mooiman, S. J. Santos, M. M. ten Dam, H. Gelderblom, C. J. Melief, P. C. Hogendoorn, R. M. Egeler, M. J. van Tol, et al. 2008. NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Mol. Immunol. 45: 3917-3925.
26. Fanger, M. W., E. D. Ball, and D. L. Drakeman. 1995. Comments on the Fourth International Conference on Bispecific Antibodies and Cellular Cytotoxicity, Duck Key, Florida, March 1-5, 1995. J. Hematother. 4: 345-349.
27. Beyer, T., S. Lohse, S. Berger, M. Peipp, T. Valerius, and M. Dechant. 2009. Serum-free production and purification of chimeric IgA antibodies. J. Immunol. Methods 346: 26-37.
28. Heuff, G., J. J. Steenbergen, A. A. Van de Loosdrecht, I. Sirovich, C. D. Dijkstra, S. Meyer, and R. H. Beelen. 1993. Isolation of cytotoxic Kupffer cells by a modified enzymatic assay: a methodological study. J. Immunol. Methods 159: 115-123.
29. Otten, M. A., J. H. Leusen, E. Rudolph, J. A. van der Linden, R. H. Beelen, J. G. van de Winkel, and M. van Egmond. 2007. FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI. J. Immunol. 179: 2918-2924.
30. Shi, L., R. P. Kraut, R. Aebersold, and A. H. Greenberg. 1992. A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 175: 553-566.
31. Tafani, M., D. A. Minchenko, A. Serroni, and J. L. Farber. 2001. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res. 61: 2459-2466.
32. Bener Aksam, E., H. Jungwirth, S. D. Kohlwein, J. Ring, F. Madeo, M. Veenhuis, and I. J. van der Klei. 2008. Absence of the peroxiredoxin Pmp20 causes peroxisomal protein leakage and necrotic cell death. Free Radic. Biol. Med. 45: 1115-1124.
33. Borregaard, N., O. E. Sørensen, and K. Theilgaard-Mönch. 2007. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 28: 340-345. (Pubitemid 47077924)
34. Marsden, V. S., and A. Strasser. 2003. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21: 71-105.
35. Lum, J. J., D. E. Bauer, M. Kong, M. H. Harris, C. Li, T. Lindsten, and C. B. Thompson. 2005. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120: 237-248.
36. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6: 655-661. (Pubitemid 27305728)
37. Shresta, S., C. T. Pham, D. A. Thomas, T. A. Graubert, and T. J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10: 581-587.
38. Uchida, J., Y. Hamaguchi, J. A. Oliver, J. V. Ravetch, J. C. Poe, K. M. Haas, and T. F. Tedder. 2004. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 199: 1659-1669.
39. Dechant, M., and T. Valerius. 2001. IgA antibodies for cancer therapy. Crit. Rev. Oncol. Hematol. 39: 69-77.
40. van der Steen, L., C. W. Tuk, J. E. Bakema, G. Kooij, A. Reijerkerk, G. Vidarsson, G. Bouma, G. Kraal, H. E. de Vries, R. H. Beelen, and M. van Egmond. 2009. Immunoglobulin A: FcalphaRI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology 137: 2018-2029.
41. Stockmeyer, B., T. Beyer, W. Neuhuber, R. Repp, J. R. Kalden, T. Valerius, and M. Herrmann. 2003. Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells. J. Immunol. 171: 5124-5129. (Pubitemid 37432795)
42. Metelitsa, L. S., S. D. Gillies, M. Super, H. Shimada, C. P. Reynolds, and R. C. Seeger. 2002. Antidisialoganglioside/granulocyte macrophage-colony- stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis. Blood 99: 4166-4173.
43. Cassatella, M. A. 2006. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J. Leukoc. Biol. 79: 1140-1149.
44. Metkar, S. S., and C. J. Froelich. 2004. Human neutrophils lack granzyme A, granzyme B, and perforin. Blood 104: 905-906, author reply 907-908.
45. Wagner, C., C. Iking-Konert, B. Denefleh, S. Stegmaier, F. Hug, and G. M. Hänsch. 2004. Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils. Blood 103: 1099-1104.
46. de Bruin, E. C., and J. P. Medema. 2008. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat. Rev. 34: 737-749.
47. Mashima, T., and T. Tsuruo. 2005. Defects of the apoptotic pathway as therapeutic target against cancer. Drug Resist. Updat. 8: 339-343.
48. Moretti, L., E. S. Yang, K. W. Kim, and B. Lu. 2007. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist. Updat. 10: 135-143.